Friday - March 20, 2026
Mount Sinai Study Identifies Inflammatory Immune Pathway Driving Immunotherapy Resistance in Bladder Cancer
March 18, 2026
NEW YORK, March 18 [Category: BizHospital] -- Mount Sinai Health System posted the following news release:

* * *

Mount Sinai Study Identifies Inflammatory Immune Pathway Driving Immunotherapy Resistance in Bladder Cancer

*

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps explain why some bladder cancers do not respond well to immunotherapy. Their f . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products